Johnson & Johnson Risperdal verdict: Company hit with $8B verdict after drug linked to boy growing breasts

A Philadelphia jury has ordered medical company Johnson & Johnson to pay $8 billion dollars in punitive damages in the case of a man who said he developed breasts after taking the company’s anti-psychotic drug Risperdal. The case is unrelated to a string of big-money lawsuits the company is facing over its signature baby powder

In the Risperdal case, a jury found that Johnson & Johnson failed to warn 26-year-old Nicholas Murray of the drug’s side effects. Murray claimed that taking the Risperdal as a child caused him to develop breasts, the result of an incurable condition known as gynecomastia. Thousands of others have filed lawsuits alleging the same.   

Murray said he was prescribed the medicine at age 9 for symptoms related to autism spectrum disorder, despite the fact that the FDA approved the drug to treat schizophrenia and episodes of bipolar mania in adults.

Attorneys for Murray alleged the company marketed the drug for unapproved, off-label use in children to increase profits, choosing “billions over children.”

Johnson & Johnson denied the allegations, and said it’s confident the ruling will be overturned. In a statement, the company said it was “precluded from presenting … key evidence…” The company further claimed that evidence showed how the label for the drug “clearly and appropriately outlined the risks associated with the medicine.” 

Murray’s attorneys told “CBS This Morning” consumer investigative correspondent Anna Werner that the punitive damages were meant to deter the company from similar conduct in the future. They believe the decision will stand.

© 2019 CBS Interactive Inc. All Rights Reserved.

Source link

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button